Literature DB >> 28814667

Adrenergic-mediated increases in INHBA drive CAF phenotype and collagens.

Archana S Nagaraja1, Robert L Dood1, Guillermo Armaiz-Pena1, Yu Kang1, Sherry Y Wu1, Julie K Allen1, Nicholas B Jennings1, Lingegowda S Mangala1, Sunila Pradeep1, Yasmin Lyons1, Monika Haemmerle1, Kshipra M Gharpure1, Nouara C Sadaoui1, Cristian Rodriguez-Aguayo2,3, Cristina Ivan2, Ying Wang4, Keith Baggerly4, Prahlad Ram5, Gabriel Lopez-Berestein2,3, Jinsong Liu6, Samuel C Mok1, Lorenzo Cohen7, Susan K Lutgendorf8, Steve W Cole9, Anil K Sood1,2,10.   

Abstract

Adrenergic signaling is known to promote tumor growth and metastasis, but the effects on tumor stroma are not well understood. An unbiased bioinformatics approach analyzing tumor samples from patients with known biobehavioral profiles identified a prominent stromal signature associated with cancer-associated fibroblasts (CAFs) in those with a high biobehavioral risk profile (high Center for Epidemiologic Studies Depression Scale [CES-D] score and low social support). In several models of epithelial ovarian cancer, daily restraint stress resulted in significantly increased CAF activation and was abrogated by a nonspecific β-blocker. Adrenergic signaling-induced CAFs had significantly higher levels of collagen and extracellular matrix components than control tumors. Using a systems-based approach, we found INHBA production by cancer cells to induce CAFs. Ablating inhibin β A decreased CAF phenotype both in vitro and in vivo. In preclinical models of breast and colon cancers, there were increased CAFs and collagens following daily restraint stress. In an independent data set of renal cell carcinoma patients, there was an association between high depression (CES-D) scores and elevated expression of ACTA2, collagens, and inhibin β A. Collectively, our findings implicate adrenergic influences on tumor stroma as important drivers of CAFs and establish inhibin β A as an important regulator of the CAF phenotype in ovarian cancer.

Entities:  

Keywords:  Cell Biology; Oncology

Year:  2017        PMID: 28814667      PMCID: PMC5621917          DOI: 10.1172/jci.insight.93076

Source DB:  PubMed          Journal:  JCI Insight        ISSN: 2379-3708


  42 in total

1.  β-Blockers and survival among Danish patients with malignant melanoma: a population-based cohort study.

Authors:  Stanley Lemeshow; Henrik Toft Sørensen; Gary Phillips; Eric V Yang; Sussie Antonsen; Anders H Riis; Gregory B Lesinski; Rebecca Jackson; Ronald Glaser
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2011-09-20       Impact factor: 4.254

2.  Upregulation of Periostin and Reactive Stroma Is Associated with Primary Chemoresistance and Predicts Clinical Outcomes in Epithelial Ovarian Cancer.

Authors:  Lisa Ryner; Yinghui Guan; Ron Firestein; Yuanyuan Xiao; Younjeong Choi; Christina Rabe; Shan Lu; Eloisa Fuentes; Ling-Yuh Huw; Mark R Lackner; Ling Fu; Lukas C Amler; Carlos Bais; Yulei Wang
Journal:  Clin Cancer Res       Date:  2015-04-02       Impact factor: 12.531

3.  Depletion of Carcinoma-Associated Fibroblasts and Fibrosis Induces Immunosuppression and Accelerates Pancreas Cancer with Reduced Survival.

Authors:  Berna C Özdemir; Tsvetelina Pentcheva-Hoang; Julienne L Carstens; Xiaofeng Zheng; Chia-Chin Wu; Tyler R Simpson; Hanane Laklai; Hikaru Sugimoto; Christoph Kahlert; Sergey V Novitskiy; Ana De Jesus-Acosta; Padmanee Sharma; Pedram Heidari; Umar Mahmood; Lynda Chin; Harold L Moses; Valerie M Weaver; Anirban Maitra; James P Allison; Valerie S LeBleu; Raghu Kalluri
Journal:  Cancer Cell       Date:  2015-12-14       Impact factor: 31.743

Review 4.  Fibroblasts in cancer.

Authors:  Raghu Kalluri; Michael Zeisberg
Journal:  Nat Rev Cancer       Date:  2006-05       Impact factor: 60.716

5.  Activin signal promotes cancer progression and is involved in cachexia in a subset of pancreatic cancer.

Authors:  Yosuke Togashi; Akihiro Kogita; Hiroki Sakamoto; Hidetoshi Hayashi; Masato Terashima; Marco A de Velasco; Kazuko Sakai; Yoshihiko Fujita; Shuta Tomida; Masayuki Kitano; Kiyotaka Okuno; Masatoshi Kudo; Kazuto Nishio
Journal:  Cancer Lett       Date:  2014-11-04       Impact factor: 8.679

Review 6.  The biology and function of fibroblasts in cancer.

Authors:  Raghu Kalluri
Journal:  Nat Rev Cancer       Date:  2016-08-23       Impact factor: 60.716

7.  Role of Activin A and myostatin in human cancer cachexia.

Authors:  Audrey Loumaye; Marie de Barsy; Maxime Nachit; Pascale Lause; Lena Frateur; Aline van Maanen; Pierre Trefois; Damien Gruson; Jean-Paul Thissen
Journal:  J Clin Endocrinol Metab       Date:  2015-03-09       Impact factor: 5.958

8.  Depressive symptoms and cortisol rhythmicity predict survival in patients with renal cell carcinoma: role of inflammatory signaling.

Authors:  Lorenzo Cohen; Steven W Cole; Anil K Sood; Sarah Prinsloo; Clemens Kirschbaum; Jesusa M G Arevalo; Nicholas B Jennings; Shellie Scott; Luis Vence; Qi Wei; Diane Kentor; Laszlo Radvanyi; Nizar Tannir; Eric Jonasch; Pheroze Tamboli; Louis Pisters
Journal:  PLoS One       Date:  2012-08-01       Impact factor: 3.240

9.  Autocrine effects of tumor-derived complement.

Authors:  Min Soon Cho; Hernan G Vasquez; Rajesha Rupaimoole; Sunila Pradeep; Sherry Wu; Behrouz Zand; Hee-Dong Han; Cristian Rodriguez-Aguayo; Justin Bottsford-Miller; Jie Huang; Takahito Miyake; Hyun-Jin Choi; Heather J Dalton; Cristina Ivan; Keith Baggerly; Gabriel Lopez-Berestein; Anil K Sood; Vahid Afshar-Kharghan
Journal:  Cell Rep       Date:  2014-03-06       Impact factor: 9.423

10.  Sustained adrenergic signaling leads to increased metastasis in ovarian cancer via increased PGE2 synthesis.

Authors:  A S Nagaraja; P L Dorniak; N C Sadaoui; Y Kang; T Lin; G Armaiz-Pena; S Y Wu; R Rupaimoole; J K Allen; K M Gharpure; S Pradeep; B Zand; R A Previs; J M Hansen; C Ivan; C Rodriguez-Aguayo; P Yang; G Lopez-Berestein; S K Lutgendorf; S W Cole; A K Sood
Journal:  Oncogene       Date:  2015-08-10       Impact factor: 9.867

View more
  11 in total

1.  Imaging Mass Spectrometry Reveals Crosstalk between the Fallopian Tube and the Ovary that Drives Primary Metastasis of Ovarian Cancer.

Authors:  Katherine E Zink; Matthew Dean; Joanna E Burdette; Laura M Sanchez
Journal:  ACS Cent Sci       Date:  2018-10-09       Impact factor: 14.553

2.  Ratio of the interferon-γ signature to the immunosuppression signature predicts anti-PD-1 therapy response in melanoma.

Authors:  Chuanliang Cui; Canqiang Xu; Wenxian Yang; Zhihong Chi; Xinan Sheng; Lu Si; Yihong Xie; Jinyu Yu; Shun Wang; Rongshan Yu; Jun Guo; Yan Kong
Journal:  NPJ Genom Med       Date:  2021-02-04       Impact factor: 8.617

3.  Tristetraprolin expression by keratinocytes protects against skin carcinogenesis.

Authors:  Assiya Assabban; Ingrid Dubois-Vedrenne; Laurye Van Maele; Rosalba Salcedo; Brittany L Snyder; Lecong Zhou; Abdulkader Azouz; Bérengère de Toeuf; Gaëlle Lapouge; Caroline La; Maxime Melchior; Muriel Nguyen; Séverine Thomas; Si Fan Wu; Wenqian Hu; Véronique Kruys; Cédric Blanpain; Giorgio Trinchieri; Cyril Gueydan; Perry J Blackshear; Stanislas Goriely
Journal:  JCI Insight       Date:  2021-03-08

Review 4.  Stress reduction strategies in breast cancer: review of pharmacologic and non-pharmacologic based strategies.

Authors:  Rohit Gosain; Elizabeth Gage-Bouchard; Christine Ambrosone; Elizabeth Repasky; Shipra Gandhi
Journal:  Semin Immunopathol       Date:  2020-09-18       Impact factor: 9.623

Review 5.  Adrenergic Signaling: A Targetable Checkpoint Limiting Development of the Antitumor Immune Response.

Authors:  Guanxi Qiao; Minhui Chen; Mark J Bucsek; Elizabeth A Repasky; Bonnie L Hylander
Journal:  Front Immunol       Date:  2018-02-06       Impact factor: 7.561

6.  The IL1β-IL1R signaling is involved in the stimulatory effects triggered by hypoxia in breast cancer cells and cancer-associated fibroblasts (CAFs).

Authors:  Rosamaria Lappano; Marianna Talia; Francesca Cirillo; Damiano Cosimo Rigiracciolo; Domenica Scordamaglia; Rita Guzzi; Anna Maria Miglietta; Ernestina Marianna De Francesco; Antonino Belfiore; Andrew H Sims; Marcello Maggiolini
Journal:  J Exp Clin Cancer Res       Date:  2020-08-10

Review 7.  Cancer Associated Fibroblasts: Naughty Neighbors That Drive Ovarian Cancer Progression.

Authors:  Subramanyam Dasari; Yiming Fang; Anirban K Mitra
Journal:  Cancers (Basel)       Date:  2018-10-29       Impact factor: 6.639

8.  Protein expression patterns in cancer-associated fibroblasts and cells undergoing the epithelial-mesenchymal transition in ovarian cancers.

Authors:  Daisuke Fukagawa; Tamotsu Sugai; Mitsumasa Osakabe; Yasuko Suga; Takayuki Nagasawa; Hiroaki Itamochi; Toru Sugiyama
Journal:  Oncotarget       Date:  2018-06-08

9.  Propranolol and breast cancer-a work in progress.

Authors:  Pan Pantziarka; Brad A Bryan; Sergio Crispino; Erin B Dickerson
Journal:  Ecancermedicalscience       Date:  2018-06-18

10.  A paracrine activin A-mDia2 axis promotes squamous carcinogenesis via fibroblast reprogramming.

Authors:  Michael Cangkrama; Mateusz Wietecha; Nicolas Mathis; Rin Okumura; Luca Ferrarese; Dunja Al-Nuaimi; Maria Antsiferova; Reinhard Dummer; Metello Innocenti; Sabine Werner
Journal:  EMBO Mol Med       Date:  2020-03-09       Impact factor: 12.137

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.